What Anlitiks does

Anlitiks Inc. is a US-incorporated, privately held health economics and outcomes research (HEOR) and real-world evidence (RWE) consultancy founded in 2021 and headquartered in Iselin, New Jersey, with a secondary office in Windermere, Florida. The firm targets major pharmaceutical and biotechnology companies, delivering services spanning systematic literature reviews, economic modeling, RWE studies, value dossiers, market access support, and publication support. Its customer base spans psychiatry/neurology, nephrology, oncology, and infectious disease, with named enterprise engagements for Acadia Pharmaceuticals, CorMedix, Kite Pharma, and Takeda Pharmaceuticals, evidenced through peer-reviewed publications and conference posters. The company also serves adjacent segments including healthcare payers/HTA bodies and market access teams.

The firm's core product is RapidAnalyzer, a proprietary analytics platform that supports the full RWE lifecycle from data cleaning through visualization, drawing on large-scale healthcare administrative databases (Medicare, Medicaid, Truven/IBM, Optum), electronic medical records, and registries. The platform is positioned to reduce time-to-insight from months to weeks and is registered as a trademark. Anlitiks pairs this technology with consultative expert partnership across HEOR, epidemiology, bioinformatics, and statistical programming (SAS, R, SPSS, STATA, SQL), operating a 'data-platform-service' delivery model.

The business model combines professional services revenue from HEOR consulting engagements with platform-enabled analytics revenue, sold through direct enterprise sales to pharma clients via strategic account relationships. Pricing is project-based and not publicly disclosed. Go-to-market emphasizes thought leadership, conference participation (ISPOR, AMCP, ASN, ASH, CTAD, NEI, AGS), LinkedIn engagement, and downloadable case studies. The firm has grown headcount by more than 10x in the past year and has attracted undisclosed strategic investment to support further expansion. Leadership comprises at least one named executive, Chief Scientific Officer Kitty Rajagopalan.

Name

Anlitiks

Legal name

ANLITIKS INC.

Website

https://anlitiks.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Anlitiks is a US-based HEOR and real-world evidence consultancy founded in 2021 that helps pharmaceutical and biotechnology companies translate large-scale healthcare data into value evidence and market access insights via its proprietary RapidAnalyzer platform, with headquarters in Iselin, New Jersey.

Ownership category

akta.pro rank

Product category

Health Economics & Outcomes Research Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Real-World Evidence (RWE) & HEOR for Development (HLAIALAI)

akta.pro secondary industries

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

Keywords

• Real-world evidence services
• Health economics outcomes research
• HEOR consulting
• RWE analytics
• Market access support

Headquarters

HQ city

Dover

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. HEOR Consulting Services: Professional services revenue from health economics and outcomes research consulting engagements with pharmaceutical and biotech companies. Services include systematic literature reviews, economic modeling, RWE studies, and value communication support.
2. Platform-Enabled Analytics: Revenue generated through the RapidAnalyzer platform providing data analytics services to clients. The platform supports the entire analytical lifecycle from data cleaning to visualization.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Anlitiks is a boutique consulting firm that provides Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) services to pharmaceutical and biotech companies. The firm combines expert consultative partnership with its proprietary RapidAnalyzer analytics platform to translate large-scale healthcare data into value evidence, reducing time-to-insight from months to weeks. Service offerings include systematic literature reviews, health economic modeling, RWE studies, value dossiers, and market access support.

Product overview

Anlitiks operates as a Real-World Evidence (RWE) and Health Economics Outcomes Research (HEOR) consultancy offering the RapidAnalyzerTM platform as its core product. RapidAnalyzerTM is a proprietary analytics platform that enables clients to translate real-world data into value evidence and insights. The company provides a comprehensive suite of services including HEOR research, health economic modeling, value communication/market access support, and communication/publication support. The unique data-platform-service model combines expert consultative partnership with technology-enabled efficiency to optimize evidence generation and data-driven decision-making for healthcare outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• RapidAnalyzer™ A proprietary data analytics platform and tool suite used to conduct real-world evidence studies. It supports the entire analytical lifecycle from data cleaning through visualization and reduces time-to-insight on large-scale healthcare data from months to weeks.
• HEOR & RWE Consulting Services Health Economics and Outcomes Research consulting engagements including systematic literature reviews, economic modeling, RWE studies, and value communication support tailored to pharmaceutical and biotech companies.
• Value Communication & Market Access Support Development of value dossiers and related deliverables to support pharmaceutical market access teams in payer negotiations, formulary placement, and articulating clinical, economic, and patient-centered benefits of interventions.
• Systematic & Targeted Literature Reviews Evidence synthesis services covering systematic and targeted literature reviews, surveys, preference-based outcome models, discrete choice experiments, and EMR/chart reviews for biopharma clients.

Quantifiable outcome

• Reduces time to gain valuable insights on large-scale data from months to weeks

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Trinity Life Sciences: Life sciences strategic advisory with strong evidence generation, HEOR, and market access practices serving top-20 pharma. Closely comparable in deliverable mix (value dossiers, evidence synthesis, payer engagement).
• Evidera (PPD / Thermo Fisher Scientific): Dedicated HEOR, RWE, and market access consultancy serving pharma clients with evidence generation, modeling, and value communication services. Closely aligned with Anlitiks' service portfolio and customer base.
• Analysis Group: Economic and outcomes research consultancy delivering HEOR, burden-of-illness, cost-effectiveness, and RWE studies to pharma/biotech clients. Direct comparable for evidence-generation and peer-reviewed publication capabilities.
• PRECISIONheor (Precision Medicine Group): Specialist HEOR and value evidence practice within the Precision Medicine Group serving biopharma with economic modeling, RWE, and market access work. Direct comparable in scope and customer profile to Anlitiks.

Broad incumbents

• Veradigm (formerly Practice Fusion / Allscripts): Provider of real-world clinical and claims data alongside research services to support HEOR and RWE. Comparable on the data-and-platform dimension of Anlitiks' offering, though primarily a data vendor rather than a service-led HEOR shop.
• HealthCore (Elevance Health): Health economics and outcomes research subsidiary of a major payer, providing RWE studies using administrative claims data. Comparable to Anlitiks in delivering HEOR/RWE research to pharma, with unique advantages from embedded payer data.
• Optum (UnitedHealth Group): Diversified healthcare analytics and research provider with proprietary claims and EHR datasets supporting HEOR/RWE studies for pharma. Overlaps heavily with Anlitiks' analytics and real-world data service line, but at substantially larger scale.
• IQVIA: Largest commercial RWE/HEOR provider with proprietary data assets (including IQVIA claims, EHR, and registry data) and end-to-end HEOR services. Directly comparable as a comprehensive RWE/HEOR services vendor to pharmaceutical clients, but at vastly greater scale.

Emerging players

• Clarify Health Solutions: Real-world evidence and value-based care analytics platform serving life sciences and payers with longitudinal patient analytics. Comparable platform-enabled RWE analytics approach targeting similar pharma customers.
• PurpleLab: Real-world data and analytics company offering claims and EHR-linked analytics for HEOR and RWE studies. Smaller and more emerging than Anlitiks, but a comparable boutique-style platform-enabled RWE/HEOR model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/anlitiks-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anlitiks